Brain tumors in Sweden: Data from a population-based registry 1999-2012

Acta Oncologica

Volumn 54, Issue 3, 2015, Pages 377-384

  Asklund, Thomas ^a   Malmström, Annika ^b   Bergqvist, Michael ^c,d   Björ, Ove ^a   Henriksson, Roger ^a,e  

^a UMEÅ UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d GÄVLE HOSPITAL   (Sweden)

^e Regional Cancer Center Stockholm   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BRAIN NEOPLASMS; EPIDEMIOLOGY; GEOGRAPHY, MEDICAL; GLIOMA; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS; TIME-TO-TREATMENT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BRAIN NEOPLASMS; GEOGRAPHY, MEDICAL; GLIOMA; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS; TIME-TO-TREATMENT;

EID: 84924229507     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.975369     Document Type: Article

References (16)

1. Wohrer A, Waldhor T, Heinzl H, Hackl M, Feichtinger J, Gruber-Mosenbacher U, et al. The Austrian Brain Tumor Registry: A cooperative way to establish a population-based brain tumour registry. J Neurooncol 2009;95:401-11.
2. Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, et al. Descriptive epidemiology of CNS tumors in France: Results from the Gironde Registry for the period 2000-2007. Neuro Oncol 2011;13:1370-8.
3. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012;14(Suppl 5):v1-49.
4. Kaneko S, Nomura K, Yoshimura T, Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973-1993. J Neurooncol 2002;60:61-9.
5. Ronning PA, Helseth E, Meling TR, Johannesen TB. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro Oncol 2012;14:1178-84.
6. Sehmer EA, Hall GJ, Greenberg DC, O'Hara C, Wallingford SC, Wright KA, et al. Incidence of glioma in a northwestern region of England, 2006-2010. Neuro Oncol 2014;16:971-4.
7. Asklund T, Malmström A, Björ O, Blomquist E, Henriksson R. Considerable improvement in survival for patients aged 60-84 years with high-grade malignant gliomas - data from the Swedish Brain Tumour Population-based Registry. Acta Oncol 2013;52:1041-3.
8. Asklund T, Björ O, Malmström A, Blomquist E, Henriksson R. [Survival in malignant gliomas has increased the last decade. Analysis of quality data]. [Article in Swedish]. Läkartidningen 2012;109:875-8.
9. Bergenheim T, Malmström A, Bolander H, Michanek A, Stragliotto G, Damber L, et al. [Registration on regional basis of patients with primary brain tumors. Regional differences disclosed]. [Article in Swedish]. Läkartidningen 2007;104:332-8, 340-1.
10. Clarke JL, Chang SM. Neuroimaging: Diagnosis and response assessment in glioblastoma. Cancer J 2012;18:26-31.
11. Irwin C, Hunn M, Purdie G, Hamilton D. Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 2007;85:339-43.
12. Lawrence YR, Blumenthal DT, Matceyevsky D, Kanner AA, Bokstein F, Corn BW. Delayed initiation of radiotherapy for glioblastoma: How important is it to push to the front (or the back) of the line? J Neurooncol 2011;105:1-7.
13. Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, et al. Extent of resection in patients with glioblastoma: Limiting factors, perception of resectability, and effect on survival. J Neurosurg 2012;117:851-9.
14. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2014;115:3-8.
15. Weller M, Bent M, Hopkins K, Tonn JC, Stupp R, Henriksson R, et al for the European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncology 2014;15:e395-403.
16. Henriksson R, Asklund T, Poulsen HS. Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastomamultiforme: A review. J Neurooncol 2011;104: 639-46.